Sharon K Inouye Selected Research

Institutionalization (Institutionalized Persons)

1/2022	Discharge Destinations of Delirious Patients: Findings From a Prospective Cohort Study of 27,026 Patients From a Large Health Care System.
10/2018	Hospital Elder Life Program: Systematic Review and Meta-analysis of Effectiveness.
9/2015	Preoperative risk factors for postoperative delirium following hip fracture repair: a systematic review.
6/2015	Brain atrophy and white-matter hyperintensities are not significantly associated with incidence and severity of postoperative delirium in older persons without dementia.
4/2015	Effectiveness of multicomponent nonpharmacological delirium interventions: a meta-analysis.
6/2012	Adverse outcomes after hospitalization and delirium in persons with Alzheimer disease.
8/2009	The overlap syndrome of depression and delirium in older hospitalized patients.
8/2006	Older adults discharged from the hospital with delirium: 1-year outcomes.
10/2002	Delirium superimposed on dementia: a systematic review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sharon K Inouye Research Topics

Disease

86	Delirium 03/2022 - 10/2002
20	Emergence Delirium 01/2022 - 09/2014
20	Dementia (Dementias) 01/2021 - 10/2002
11	Cognitive Dysfunction 09/2021 - 12/2003
7	Confusion (Bewilderment) 03/2022 - 08/2009
5	Inflammation (Inflammations) 04/2022 - 11/2017
3	Frailty 01/2022 - 12/2016
3	Alzheimer Disease (Alzheimer's Disease) 12/2021 - 12/2012
3	Stroke (Strokes) 11/2020 - 04/2006
2	Neuroinflammatory Diseases 04/2022 - 01/2020
2	Critical Illness (Critically Ill) 01/2021 - 01/2006
2	Dehydration (Water Stress) 05/2017 - 04/2014
2	Pressure Ulcer (Bedsore) 05/2017 - 01/2017
2	Surgical Wound 01/2017 - 09/2014
2	Pain (Aches) 01/2017 - 04/2014
2	Infections 01/2016 - 04/2014
1	COVID-19 01/2022
1	Multiple Chronic Conditions 01/2022
1	Abdominal Aortic Aneurysm 01/2021
1	Hearing Loss (Hearing Impairment) 11/2020
1	Parkinson Disease (Parkinson's Disease) 11/2020
1	Hypotension (Low Blood Pressure) 01/2019
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2017
1	Aspiration Pneumonia 05/2017
1	Sleep Deprivation 05/2017
1	Malnutrition (Nutritional Deficiencies) 05/2017
1	Iatrogenic Disease 05/2017
1	Hallucinations (Hallucination) 01/2017
1	Hemorrhage 01/2017
1	Chemotherapy-Related Cognitive Impairment 01/2016
1	Neoplasms (Cancer) 01/2016
1	Postoperative Pain 09/2014

Drug/Important Bio-Agent (IBA)

17	Biomarkers (Surrogate Marker)IBA 04/2022 - 12/2006
6	Proteins (Proteins, Gene)FDA Link 04/2022 - 12/2006
6	C-Reactive ProteinIBA 01/2022 - 01/2017
5	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 08/2012
4	Interleukin-6 (Interleukin 6)IBA 01/2022 - 10/2015
4	EnzymesIBA 01/2021 - 07/2008
4	Indicators and Reagents (Reagents)IBA 03/2014 - 03/2011
3	BenzodiazepinesIBA 01/2022 - 08/2007
3	Opioid Analgesics (Opioids)IBA 01/2022 - 01/2009
3	ApolipoproteinsIBA 01/2020 - 10/2015
3	CytokinesIBA 06/2017 - 11/2012
3	AlbuminsIBA 09/2015 - 01/2003
3	Pharmaceutical PreparationsIBA 08/2012 - 04/2006
2	ProteomeIBA 04/2022 - 01/2022
2	Blood Proteins (Serum Proteins)IBA 04/2022 - 01/2022
2	ImmunosorbentsIBA 01/2021 - 01/2017
2	Apolipoproteins E (ApoE)IBA 01/2020 - 10/2015
2	Anesthetics (Anesthetic Agents)IBA 01/2019 - 01/2019
2	Ketamine FDA LinkGeneric 01/2017 - 09/2014
2	Antidepressive Agents (Antidepressants)IBA 08/2012 - 05/2007
2	Cholinergic Agents (Cholinergics)IBA 03/2011 - 07/2008
2	Hypnotics and Sedatives (Sedatives)IBA 01/2008 - 04/2004
2	CreatinineIBA 08/2007 - 01/2003
1	Biological ProductsIBA 04/2022
1	N 556IBA 01/2022
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	Chitinase-3-Like Protein 1IBA 01/2022
1	nasIBA 01/2021
1	Amino Acids FDA Link 01/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	HydrolasesIBA 11/2020
1	UbiquitinIBA 11/2020
1	Glial Fibrillary Acidic ProteinIBA 11/2020
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2019
1	Interleukin-2 (IL2)IBA 01/2019
1	InterleukinsIBA 01/2019
1	methionylmethionine (Met-Met)IBA 01/2019
1	valylvaline (Val-Val)IBA 01/2019
1	imidazole mustard (BIC)IBA 01/2019
1	CatecholaminesIBA 01/2019
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 01/2019
1	Saline SolutionIBA 01/2017
1	ORALIT (ORS)IBA 04/2016

Therapy/Procedure

26	Length of Stay 03/2022 - 04/2004
14	Home Nursing (Nursing, Home) 01/2022 - 04/2003
9	Institutionalization (Institutionalized Persons) 01/2022 - 10/2002
7	Activities of Daily Living (ADL) 09/2021 - 12/2003
4	Critical Care (Surgical Intensive Care) 03/2022 - 12/2003
4	Patient Readmission 01/2021 - 10/2002
4	Orthopedic Procedures 01/2020 - 11/2014
4	Long-Term Care 10/2018 - 04/2015
4	Subacute Care 07/2017 - 01/2009
3	Spinal Anesthesia 04/2022 - 01/2020
3	Operative Surgical Procedures 01/2021 - 10/2015
3	General Anesthesia 01/2019 - 01/2018
3	Anesthesia 01/2019 - 12/2006
2	Polypharmacy 01/2022 - 09/2015
2	Transitional Care 01/2017 - 08/2006
1	Nursing Care 12/2021
1	Arthroplasty 01/2021
1	Colectomy 01/2021
1	Laminectomy 01/2021
1	Transcranial Magnetic Stimulation 06/2017
1	Urinary Catheters 05/2017
1	Analgesia 01/2017
1	Therapeutics 01/2017
1	Drug Therapy (Chemotherapy) 01/2016